Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Giovanni Traverso
AddedFeb 13, 2024
UpdatedMay 31, 2026
Giovanni Traverso

Giovanni Traverso

Co-Founder, Celero Systems

CrunchbaseLinkedInThe Org

Giovanni Traverso's Career

Celero Systems
Celero Systems

Lincoln, MA, US

Co-Founder
Teal Bio
Teal Bio

Somerville, MA, US

Co-Founder
Syntis Bio
Syntis Bio

Milton, MA, US

Co-Founder
Lyndra
Lyndra

Watertown, MA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Giovanni Traverso's Career

Celero Systems
Celero Systems
Seed$3M62017Lincoln, MA, US
Co-Founder

Leadership at Celero Systems

Ben PlessBen PlessCo-Founder & CEO
Steven WeinsteinSteven WeinsteinBoard Member
Teal Bio
Teal Bio
Series A$3.6M62020Somerville, MA, US
Co-Founder

Leadership at Teal Bio

Jason TroutnerJason TroutnerCo-Founder
Adam WentworthAdam WentworthCo-Founder
Tony CascianoTony CascianoCEO

Similar to Teal Bio

Tela BioTela BioMalvern, PA, USBiomaterials, Surgicalest. 2012Tela BioMalvern, PA, US · est. 2012

Tela Bio, Inc.: A US-based biotech firm specializing in surgical soft tissue repair and reconstruction.

Public · $230.4M123
TelesairTelesairIrvine, CA, USMedical Devicesest. 2020TelesairIrvine, CA, US · est. 2020

Telesair: An Irvine-based startup innovating mobile respiratory care for faster home recovery.

Series A · $22M30
Tealtech MMOTealtech MMOSan Diego, CA, USHome Healthcare, Telemedicineest. 2017Tealtech MMOSan Diego, CA, US · est. 2017

Tech provider offering an integrated platform for advanced home care solutions.

Pre-Seed · $1.2M5
Resilient LifescienceResilient LifesciencePittsburgh, PA, USMedical Devicesest. 2022Resilient LifesciencePittsburgh, PA, US · est. 2022

Resilient Lifescience: Developing wearable devices to prevent opioid overdoses.

Pre-Seed · $625k2
Syntis Bio
Syntis Bio
Series B$15.4M72022Milton, MA, US
Co-Founder

Leadership at Syntis Bio

Bob LangerBob LangerCo-Founder
Rahul DhandaRahul DhandaCo-Founder

Similar to Syntis Bio

i2o Therapeuticsi2o TherapeuticsSaratoga, CA, USDrug Deliveryest. 2019i2o TherapeuticsSaratoga, CA, US · est. 2019

i2o Therapeutics: Innovating oral formulations for traditionally injectable therapies.

Series A · $90.4M15
Synereca PharmaceuticalsSynereca PharmaceuticalsChapel Hill, NC, USDrugs, Pharmaceuticalsest. 2017Synereca PharmaceuticalsChapel Hill, NC, US · est. 2017

Synereca Pharmaceuticals innovates orally-active drugs to enhance existing antibiotics' effectiveness.

Pre-Seed · $2.3M6
Forward TherapeuticsForward TherapeuticsPalm Beach Gardens, FL, USOral Therapiesest. 2022Forward TherapeuticsPalm Beach Gardens, FL, US · est. 2022

Forward Therapeutics: Innovating chronic inflammatory treatment through advanced oral immune therapies.

Series A · $50M2
Synnovation TherapeuticsSynnovation TherapeuticsWilmington, DE, USOncology Therapiesest. 2021Synnovation TherapeuticsWilmington, DE, US · est. 2021

Synnovation Therapeutics: Precision oncology firm specializing in small molecule therapies for cancer.

Series A · $139M18
Lyndra
Lyndra
Series E$284.6M1612015Watertown, MA, US
Co-Founder

Leadership at Lyndra

Andrew BellingerAndrew BellingerCo-Founder
Zafi AvnurZafi AvnurBoard Member
Patricia HurterPatricia HurterBoard Member
Robert LangerRobert LangerCo-Founder
Colin GardnerColin GardnerCo-Founder
Catherine B. ReynoldsCatherine B. ReynoldsBoard Member

Similar to Lyndra

Lyra TherapeuticsLyra TherapeuticsWatertown, MA, USDrugs, Therapeuticsest. 2014Lyra TherapeuticsWatertown, MA, US · est. 2014

Lyra Therapeutics, Inc.: A clinical-stage biotech firm innovating localized treatments for chronic rhinosinusitis.

Public · $264.1M66
Lindy BiosciencesLindy BiosciencesDurham, NC, USDrug Deliveryest. 2017Lindy BiosciencesDurham, NC, US · est. 2017

Lindy Biosciences: A development-stage company specializing in protein therapeutic formulations.

Series B · $6.6M11
Lykos TherapeuticsLykos TherapeuticsSan Jose, CA, USPharmaceuticalsest. 2014Lykos TherapeuticsSan Jose, CA, US · est. 2014

Lykos Therapeutics: Revolutionizing mental health with innovative, science-backed psychedelic therapies.

Series A · $100M175
LydexLydexMount Pleasant, SC, USDrug Therapyest. 2017LydexMount Pleasant, SC, US · est. 2017

Lydex Pharmaceuticals: Innovating liver IR therapies for safer surgeries and transplants.

Angel · $50k8

Giovanni Traverso's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · KakaoJB LEEJB LEECo-Founder · Kakao

People Similar to Giovanni Traverso

Mark PoderisMark PoderisCo-Founder · Dolla Technologies GroupJohn MasonJohn MasonCo-Founder · CeleraJim LoCascioJim LoCascioCo-Founder · CeleraScott ManalisScott ManalisCo-Founder · TraveraC. Tony LiuC. Tony LiuFounder · Reactive Biosciences